AIA Group Ltd Purchases 109,929 Shares of Healthpeak Properties, Inc. $DOC

Key Points

• AIA Group opened a position in Healthpeak Properties, buying 109,929 shares worth approximately $2.2 million in the third quarter.
• Healthpeak’s third-quarter revenue rose 16.3% year over year, but reported EPS of $0.02 fell short of the $0.43 consensus estimate. The company raised its 2026 adjusted FFO guidance to $1.76–$1.78 per share.
• Healthpeak announced a monthly dividend of $0.1017 per share, equivalent to an annualized yield of about 6%. Analysts’ consensus rating was Hold, with an average price target of $21.47; refinancing risk remains a concern.

AIA Group Ltd bought a new stake in shares of Healthpeak Properties, Inc. (NYSE:DOC - Free Report) during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 109,929 shares of the real estate investment trust's stock, valued at approximately $2,195,000.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Pension & Wealth Management Advisors Inc. purchased a new position in Healthpeak Properties during the 3rd quarter worth $27,000. Clearstead Trust LLC boosted its stake in Healthpeak Properties by 66.7% during the second quarter. Clearstead Trust LLC now owns 1,357 shares of the real estate investment trust's stock worth $29,000 after buying an additional 543 shares during the last quarter. Security National Bank of SO Dak acquired a new position in Healthpeak Properties in the 2nd quarter valued at about $32,000. Avalon Trust Co acquired a new stake in shares of Healthpeak Properties during the first quarter valued at about $34,000. Finally, Latitude Advisors LLC acquired a new position in shares of Healthpeak Properties in the third quarter valued at approximately $34,000. Institutional investors own 93.57% of the company's stock.

Healthpeak Properties Price Performance

DOC opened at $20.19 on Thursday. Healthpeak Properties, Inc. has a 52-week low of $15.70 and a 52-week high of $22.95. The company has a 50 day moving average of $19.79 and a two-hundred day moving average of $19.17. The company has a market cap of $13.92 billion, a P/E ratio of 37.40, a P/E/G ratio of 2.41 and a beta of 1.01. The company has a quick ratio of 3.02, a current ratio of 1.29 and a debt-to-equity ratio of 0.87.

Healthpeak Properties (NYSE:DOC - Get Free Report) last announced its quarterly earnings data on Monday, November 2nd. The real estate investment trust reported $0.02 earnings per share for the quarter, missing the consensus estimate of $0.43 by ($0.41). The firm had revenue of $820.89 million during the quarter, compared to the consensus estimate of $739.18 million. Healthpeak Properties had a net margin of 12.32% and a return on equity of 4.04%. The firm's quarterly revenue was up 16.3% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.46 earnings per share. On average, analysts expect that Healthpeak Properties, Inc. will post 1.77 earnings per share for the current year.

Healthpeak Properties Announces Dividend

The business also recently announced a monthly dividend, which will be paid on Wednesday, December 30th. Shareholders of record on Friday, December 18th will be given a $0.1017 dividend. The ex-dividend date is Friday, December 18th. This represents a $1.22 dividend on an annualized basis and a yield of 6.0%. Healthpeak Properties's dividend payout ratio is presently 225.93%.

Healthpeak Properties News Roundup

Here are the key news stories impacting Healthpeak Properties this week:

• Positive Sentiment: Healthpeak raised its 2026 adjusted FFO guidance to $1.76–$1.78 per share, broadly in line with the $1.77 consensus. Management pointed to outpatient leasing and senior-housing growth, while Q3 revenue rose 16.3% year over year. Zacks article
• Positive Sentiment: Management described broad operating momentum and expects to lease up recently acquired lab properties over two to three years. A potential recovery in life-science real estate is also cited by analysts as a possible longer-term catalyst. Healthpeak guidance and lab lease-up
• Neutral Sentiment: Q3 results were mixed: adjusted FFO declined year over year, while revenue increased. Revenue also came in below one reported FactSet estimate, though it exceeded other estimates cited in coverage. Q3 results
• Negative Sentiment: Refinancing risk remains a concern, and Cantor Fitzgerald cut its price target from $23 to $21 while maintaining a neutral rating. The target reduction may limit enthusiasm despite the improved guidance. Refinancing risk coverage

Analysts Set New Price Targets

DOC has been the topic of a number of recent analyst reports. UBS Group dropped their price objective on Healthpeak Properties from $21.50 to $20.00 and set a "neutral" rating on the stock in a report on Tuesday, October 13th. Jefferies Financial Group assumed coverage on shares of Healthpeak Properties in a research report on Tuesday, September 15th. They issued a "hold" rating and a $21.00 target price on the stock. Robert W. Baird upped their price objective on shares of Healthpeak Properties from $21.00 to $24.00 and gave the company an "outperform" rating in a research note on Thursday, August 13th. Weiss Ratings cut shares of Healthpeak Properties from a "hold (c+)" rating to a "hold (c)" rating in a report on Wednesday, September 16th. Finally, Wells Fargo & Company reduced their price target on shares of Healthpeak Properties from $22.00 to $19.00 and set an "equal weight" rating for the company in a research report on Monday, October 19th. Four equities research analysts have rated the stock with a Buy rating and fourteen have given a Hold rating to the stock. Based on data from MarketBeat.com, Healthpeak Properties has a consensus rating of "Hold" and an average price target of $21.47.

About Healthpeak Properties

Healthpeak Properties, Inc NYSE: DOC is a real estate investment trust that owns, operates and develops healthcare-related real estate in the United States. The company primarily serves healthcare providers, research organizations and senior-care operators through a portfolio of specialized properties.

Its main activities include the ownership and leasing of outpatient medical office buildings, life science facilities and senior housing properties. These assets support services such as physician practices, ambulatory care, medical research and senior living.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.